Herceptin


Also found in: Medical, Wikipedia.
Related to Herceptin: HER2

Her·cep·tin

 (hər-sĕp′tn)
A trademark for the drug trastuzumab.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

Herceptin

(hərˈsɛptɪn)
n
(Pharmacology) trademark a monoclonal antibody that inhibits the protein that can fuel tumour growth, used in the treatment of breast cancer
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
References in periodicals archive ?
Key growth drivers were multiple sclerosis medicine Ocrevus and cancer medicines Perjeta and Tecentriq as well as the new haemophilia medicine Hemlibra, partially offset by lower sales of Herceptin and of MabThera/Rituxan.
M2 EQUITYBITES-March 4, 2019-US FDA grants new approvals to Roche's Herceptin Hylecta
M2 PHARMA-March 4, 2019-US FDA grants new approvals to Roche's Herceptin Hylecta
- The PrefHER patient preference study of adjuvant Herceptin Hylecta followed by intravenous Herceptin, or the reverse sequence, found the majority (86 percent) of people preferred Herceptin Hylecta over intravenous Herceptin.
Global Banking News-March 1, 2019-Halozyme wins US FDA approval for Herceptin Hylecta for treating HER2-positive early breast cancer
Food and Drug Administration has approved Herceptin Hylecta for subcutaneous injection for the treatment of certain people with HER2-positive early breast cancer in combination with chemotherapy and HER2-positive metastatic breast cancer in combination with paclitaxel or alone in people who have received one or more chemotherapy regimens for metastatic disease.
REGISTERED NURSE and breast cancer drug campaigner and survivor Chris Walsh spoke about her two-year battle with Pharmac a decade ago, to fully fund herceptin.
Genentech scientists, having cloned the first human HER2 gene earlier, create Herceptin by humanizing a mouse antibody directed at HER2.
[USPRwire, Thu Nov 27 2014] GlobalData has released its new PharmaPoint Drug Evaluation report, "Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023".
On Monday patients in the North East with HER2-positive breast cancer will begin to receive a new injection of the drug Herceptin, given just beneath the skin.
Patients currently receive the drug Herceptin via a drip, usually visiting hospital every three weeks.